Krish Subramanyam of Asit C Mehta Investment told CNBC-TV18, "Ranbaxy Laboratories looks interesting because last week’s movements indicated that it was consolidating though we saw volatility in the market, this stock was more positively inclined. Therefore, if I were to take a call on the stock then would buy 450 strike Call for possible upside."
At 14:43 hrs Ranbaxy Laboratories was quoting at Rs 448, up Rs 26.30, or 6.24 percent. Disclosure: He has recommended the stock and strategies to his clients who are holding them at large.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
